Advanced/Recurrent Breast Cancer
1 clinical trials · Condition
◉ Watch Advanced/Recurrent Breast Cancer
| Record | Firm | Date |
|---|---|---|
| A Study of Combination of Temsirolimus (Torisel®) and Pegylated Liposomal Doxorubicin (PLD, Doxil®/Caelyx®) in Advanced or Recurrent Breast, Endometrial and Ovarian Cancer (NCT00982631) | Radboud University Medical Center | 2009-06-01 |
Track Advanced/Recurrent Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.